5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.30▲ | 6.41▼ | 6.50▼ | 6.79▼ | 6.27▲ |
MA10 | 6.33▼ | 6.57▼ | 6.69▼ | 6.55▼ | 5.90▲ |
MA20 | 6.38▼ | 6.71▼ | 6.78▼ | 6.47▼ | 5.44▲ |
MA50 | 6.55▼ | 6.83▼ | 6.69▼ | 5.80▲ | 4.91▲ |
MA100 | 6.71▼ | 6.65▼ | 6.45▼ | 5.43▲ | 5.27▲ |
MA200 | 6.80▼ | 6.46▼ | 6.34▼ | 5.02▲ | 5.94▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.052▼ | -0.079▼ | -0.007▼ | 0.108▲ |
RSI | 40.159▼ | 23.509▼ | 28.747▼ | 50.420▲ | 56.297▲ |
STOCH | 23.619 | 15.734▼ | 16.720▼ | 79.937 | 71.769 |
WILL %R | -50.847 | -82.738▼ | -83.429▼ | -36.777 | -35.039 |
CCI | -130.888▼ | -138.242▼ | -173.856▼ | 16.993 | 95.600 |
Monday, March 10, 2025 04:00 AM
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today ...
|
Sunday, March 09, 2025 09:00 PM
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases ...
|
Friday, March 07, 2025 10:37 PM
Research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Aldeyra Therapeutics in a research report issued to clients and investors on Monday, March 3rd. HC ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/03/25 | 7.005 | 7.005 | 6.165 | 6.31 | 926,623 |
14/03/25 | 6.83 | 7.08 | 6.81 | 6.91 | 581,828 |
13/03/25 | 6.90 | 7.14 | 6.785 | 6.81 | 754,547 |
12/03/25 | 7.00 | 7.20 | 6.7942 | 6.98 | 639,914 |
11/03/25 | 6.66 | 6.96 | 6.58 | 6.92 | 643,886 |
10/03/25 | 6.31 | 6.66 | 6.18 | 6.62 | 747,124 |
07/03/25 | 6.28 | 6.61 | 6.18 | 6.35 | 569,237 |
06/03/25 | 5.99 | 6.35 | 5.99 | 6.29 | 480,404 |
05/03/25 | 6.19 | 6.29 | 5.85 | 6.15 | 521,223 |
04/03/25 | 5.92 | 6.39 | 5.63 | 6.17 | 902,737 |
|
|
||||
|
|
||||
|
|